With drug overdose deaths reaching record numbers, policymakers and other stakeholders must increase their efforts to end the nation’s drug overdose epidemic with targeted, evidence-based interventions and emerging best practices.
Currently, states are maintaining continuous enrollment of all Medicaid enrollees as a condition of receiving enhanced federal funding under the Families First Coronavirus Response Act.
In July 2021, Governor Kate Brown signed into law HB 2010, which charges the Oregon Health Authority with developing a potential path for a public option in Oregon that is designed to increase the number of people in Oregon with health insurance and help Oregon achieve health equity.
While most stakeholders agree on the need for more transparency in our health care system, there is substantial debate about how to make meaningful progress toward this goal in specific cases.
Under federal regulations, states may provide pregnancy-related care to targeted low-income children from conception to birth through the Children’s Health Insurance Program (CHIP) state plan (the so-called “unborn child” option).
The COVID-19 pandemic laid bare long-standing racial and ethnic health inequities and disparities across America, including in Massachusetts.
Viewed from a range of different measures, low-income residents of Mississippi are particularly disadvantaged with respect to access to health care, quality of care received, costs of care, health outcomes and income-based health care disparities.
The vision of primary care as the foundation for all health care is one shared by many who work in and around the U.S. health care system.
Sickle cell disease (SCD) is a progressively debilitating genetic condition that affects red blood cells and can result in a variety of serious medical complications, reduced life expectancy and diminished quality of life.